IP Verse

Mylan Institutional Inc. et al. vs Fresenius Kabi USA, LLC

The detailed information for PTAB case with proceeding number IPR2017-00643 filed by Mylan Institutional Inc. et al. against Fresenius Kabi USA, LLC on Jan 19, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2017-00643
Filing Date: Jan 19, 2017
Petitioner: Mylan Institutional Inc. et al.
Respondent: Fresenius Kabi USA, LLC
Status: Terminated-Settled
Respondent Application Number: 14641426
Respondent Tech Center: 1600
Respondent Patent Number: 9168238
Termination Date: Apr 19, 2017

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice of Refund	May 1, 2017	PAPER	BOARD
Petitioners Request for Refund of IPR Fees	Apr 20, 2017	PAPER	PETITIONER
Order Granting Joint Motion to Terminate the Proceeding Before Institution	Apr 19, 2017	PAPER	BOARD
Joint Motion to Terminate Proceedings Pursuant To ¿¿ 317	Apr 13, 2017	PAPER	PETITIONER
Joint Request To File Settlement Agreement As Business Confidential Information Pursuant To 35 U.S.C. ¿¿ 317(b) and 37 C.F.R. ¿¿ 42.74(c)	Apr 13, 2017	PAPER	PETITIONER
Exhibit 1058 - Confidential Settlement Agreement	Apr 13, 2017	EXHIBIT	PETITIONER
Patent Owner's Mandatory Notices	Feb 15, 2017	PAPER	PATENT OWNER
Patent Owner's Power of Attorney	Feb 15, 2017	PAPER	PATENT OWNER
Notice of Accord Filing Date	Feb 1, 2017	PAPER	BOARD
Mylan EX 1002 U.S. Patent No. 9,168,238	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1003 U.S. Patent No. 9,168,239	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1005 C V of James E. Kipp, Ph.D.	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1001 US Patent 9006289	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1008 Rowe et al., ¿¿¿Mannitol,¿¿¿	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1007 APP Levothyroxine Sodium for Inj Pres Info	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1009 Collier et al.,	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1011 U.S. Patent App. Pub. No. 2012/0190748	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1014 Declaration of Jiang et al., 08.07.13	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1015 Declaration of Leonard J. Chyall 06.05.14	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1016 Shah et al.,	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1019 Glass et al., Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1025 Carpenter et al. Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1027 U.S. Provisional Application No. 61/529,084	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1010 Baheti et al.,	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1012 Markman Opinion in No. 15-cv-3654-KM-MAH, ECF No. 327	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1013 Declaration of Arunya Usayapant 12.23.14	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1017 Chong Min Won Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1018 Brower et al., Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1021 Physician¿¿¿s Desk Reference, 25th Ed., Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1026 Amendment and Response 2014	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1037 Amendment and Response 08.09.2013	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1033 Byrn et al., Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1035 Amendment and Response dated June 6, 2014	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1036 Excerpt Richard J. Lewis, Sr., Hawley¿¿¿s Cond Chem Dict	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1038 Sznitowska et al., Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1039 Richard J. Lewis, Sr., Hawley¿¿¿s Cond Chem Dict Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1042 Akers Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1043 U.S. Patent No. 6,399,101	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1044 Amendment and Response 07.13.2015	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1045 Rowe et al., Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1047 Appeal Brief	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1049 Yu et al., Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1050 Torrado et al, Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1046 Merck Index	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1048 Kim et al., excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1051 Synthroid, Announcements	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1053 Bedford Laboratories	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1056 Smith RM, Martell AE. Critical Stability Constants Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Petitioner's Power of Attorney	Jan 19, 2017	PAPER	PETITIONER
Mylan EX 1052 U.S. Patent No. 6,284,277	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1054 Herman et al., Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1057 Brown T.L., Lemay H.E. Jr., Bursten B.E., Chemistry, Excerpt	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan EX 1006 Abbott Label	Jan 19, 2017	EXHIBIT	PETITIONER
Mylan Ex 1004 Declaration of James E. Kipp, Ph.D	Jan 19, 2017	EXHIBIT	PETITIONER
Petition for Inter Partes Review	Jan 19, 2017	PAPER	PETITIONER
Mylan Ex 1034 Fresenius Label	Jan 19, 2017	EXHIBIT	PETITIONER